Oncology Biomarker Articles & Analysis
2 news found
4D Path, a company conceived by an experienced team of scientists, clinicians and management from leading research institutions including MIT, Harvard Medical School and the University of Cambridge, has unveiled a faster, more efficient approach to cancer diagnosis and biomarker profiling with better accuracy that accelerates and democratizes precision medicine for optimized ...
On Tuesday, March 4, Dako will co-host an Exhibitor Seminar in cooperation with one of its pharmaceutical partners, Bristol-Myers Squibb, titled "Exploring Immune-Based Biomarkers in Oncology," from 5:30-7:30 p.m. in Room 29D. This seminar will update the pathology community on the importance of emerging immune therapies for the treatment of cancer and the need ...